#Hepaticencephalopathy
We are kicking off the 2025 #ObesitySeminarSeries of
IUCPQ next Tuesday, with Dr. Christopher Rose from @crchum.bsky.social @umontreal-en.bsky.social to discuss #HepaticEncephalopathy 🧠
January 7, 2025 at 6:00 PM
🧠 The modified hepatic encephalopathy staging tool (mHEST) outperformed West Haven criteria in diagnostic consistency and prognostic performance.

#POSTER TOP-471-YI by Annarein Kerbert et al.

#EASL2026
#HepaticEncephalopathy
#Cirrhosis #Hepatology

@rajivjalan.bsky.social
@europeliver.bsky.social
May 28, 2026 at 5:27 AM
🧪 SAT-209 – #EASL2025
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
May 10, 2025 at 12:22 PM
Pts w #Hepaticencephalopathy get a raw deal for #Livertransplant. Does MELD3.0 help?
🔑 we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
🔑inpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
🔑HE needs priority!⤵️
pubmed.ncbi.nlm.nih.gov/39836914/
January 23, 2025 at 3:39 AM
Hepatic Encephalopathy: Causes, Symptoms, Diagnosis, and Management
#HepaticEncephalopathy #LiverDisease #Cirrhosis #Hepatology #VikaasShandily
June 17, 2026 at 9:41 AM
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
November 27, 2025 at 3:20 PM
🧪 Silibinin meglumine (SM) shows neuroprotective promise in HE! It targets UCP2, reducing oxidative stress & mitochondrial dysfunction. SM lowers ammonia & neuroinflammation, boosting liver-brain health.

Read the full article here: doi.org/10.1016/S187...

#HepaticEncephalopathy #Silibinin #UCP2
June 11, 2026 at 1:18 PM
👏 Congratulations to Adam Buckholz, MD, MS of Weill Cornell Medicine, recipient of the 2025 Frank J. Tusa Pilot Award for Research in #HepaticEncephalopathy! His pilot study explores how melatonin may improve sleep and cognition in HE. #LiverResearch #AASLD
June 23, 2025 at 2:11 PM
Up to 13% of Dementia Cases Could Be a Misdiagnosed Treatable Condition : ScienceAlert www.sciencealert.com/up-to-13-of-... #dementia #mentalhealth #Hepaticencephalopathy
Up to 13% of Dementia Cases Could Be a Misdiagnosed Treatable Condition
As the global population ages, more of us face frightening cognitive decline, personally or in our loved ones.
www.sciencealert.com
December 22, 2024 at 4:39 PM
histology for my pathology seminary case. Ample vacuolization (spongiosis) in mid brain, hippocampus specifically. Our theory is that this degeneration was caused by a liver tumor. im so excited! #vetmedsky #vetsky #hepaticencephalopathy
September 12, 2026 at 4:25 PM
📢 Editor's Choice Review in #LiversMDPI

🧬 Synthesizes guidelines for acute OHE management in liver cirrhosis.
🩺 Highlights precipitating factors (infections, GI bleeding) & pillars.

📖 Learn More: www.mdpi.com/2673-4389/6/...

#HepaticEncephalopathy #LiverCirrhosis #Guidelines
August 3, 2026 at 7:31 AM
From @dgsomucla.bsky.social and @smidtheart.bsky.social:

High-dose #GLP1RA therapy is associated with a reduced risk for #HepaticEncephalopathy, supporting its use for patients without #LiverCancer.
Do GLP-1 RAs Reduce Hepatic Encephalopathy Risk in Cirrhosis?
High-dose GLP-1 RA use is associated with a significantly lower risk for hepatic encephalopathy and mortality in cirrhosis.
www.gastroenterologyadvisor.com
June 24, 2026 at 7:20 PM
October 18, 2023 at 5:35 PM
Integrative behavioral, histological, and proteomics profiling identifies cerebellar drivers of motor dysfunction in a rat model of hepatic encephalopathy.
Acharjee, Arup et al.
Paper
Details
#Cerebellum #HepaticEncephalopathy #Proteomics
December 28, 2025 at 9:01 AM